Dr. Reddy's Laboratories shares slip 1.04% and underperform market
Updated
Updated · MarketWatch · May 8
Dr. Reddy's Laboratories shares slip 1.04% and underperform market
15 articles · Updated · MarketWatch · May 8
The stock closed at 1,293.25 rupees on Friday as the BSE Sensex fell 0.66% to 77,328.19 in a broadly weak session.
Dr. Reddy's ended 6.15% below its 52-week high of 1,377.95 rupees, reached on June 12.
Among peers, Lupin fell 3.28%, Zydus Lifesciences slipped 0.03% and Wockhardt lost 1.89%, while Dr. Reddy's trading volume was 35,545 against a 50-day average of 94,692.
With a $100B market in sight, why are analysts souring on Dr. Reddy's despite its major generic Ozempic approval?
After its big Ozempic win, is Dr. Reddy's poised to capture the next wave of billion-dollar generic drug opportunities?